| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
5,076
|
9,780
|
6,570
|
2,429
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
5,076
|
9,780
|
6,570
|
2,429
| |
|
Operating Expenses |
|
Research Development | 10,855 | 15,645 | 12,895 | 6,326 |
|
Selling General and Administrative | 2,500 | 2,042 | 1,965 | 2,047 |
|
Non Recurring |
-
| (1,657) |
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(8,279)
|
(6,250)
|
(8,290)
|
(5,944)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 1,582 | 2,147 | 2,370 | 1,729 |
|
Earnings Before Interest And Taxes | (6,697) | (4,103) | (5,920) | (4,215) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (6,697) | (4,103) | (5,920) | (4,215) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (6,697) | (4,103) | (5,920) | (4,215) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(6,697)
|
(4,103)
|
(5,920)
|
(4,215)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(6,697)
|
(4,103)
|
(5,920)
|
(4,215)
|
|
0.37(3.64%) 2:38PM EDT - Nasdaq Real Time Price